Corporate$BBNX12:24 PM ET

Beta Bionics faces securities fraud class action over iLet FDA compliance issues

By BORSA NewsroomPublished Oct 21, 2026, 12:24 PM EDTUpdated Oct 21, 2026, 12:24 PM EDT

Hagens Berman announced a class action lawsuit against Beta Bionics (BBNX) alleging the company concealed FDA compliance issues and device safety warnings for its iLet insulin delivery system. Lead plaintiff deadline is November 3, 2026.

Sentimentbearish 20

Strongly bearish · 20 of 100

Impact70

medium · sector-wide

Confidence80%

high confidence · single wire

Eventdeveloping

v1 · alerted to followers

WHAT WE KNOW

Class period: July 30, 2025 to February 24, 2026
Lead plaintiff deadline: November 3, 2026